1. Home
  2. NEXN vs MYGN Comparison

NEXN vs MYGN Comparison

Compare NEXN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexxen International Ltd. American Depository Shares

NEXN

Nexxen International Ltd. American Depository Shares

HOLD

Current Price

$8.43

Market Cap

381.1M

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$3.98

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXN
MYGN
Founded
2007
1991
Country
Israel
United States
Employees
909
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
381.1M
444.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NEXN
MYGN
Price
$8.43
$3.98
Analyst Decision
Strong Buy
Buy
Analyst Count
8
7
Target Price
$11.56
$7.64
AVG Volume (30 Days)
247.6K
1.7M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
N/A
$5.45
P/E Ratio
$9.64
N/A
Revenue Growth
N/A
2.33
52 Week Low
$5.60
$3.53
52 Week High
$11.74
$8.59

Technical Indicators

Market Signals
Indicator
NEXN
MYGN
Relative Strength Index (RSI) 64.22 45.32
Support Level $6.03 $3.53
Resistance Level $8.50 $5.42
Average True Range (ATR) 0.45 0.23
MACD 0.03 0.04
Stochastic Oscillator 89.32 47.80

Price Performance

Historical Comparison
NEXN
MYGN

About NEXN Nexxen International Ltd. American Depository Shares

Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and TV that helps empower advertisers, agencies, digital publishers, broadcasters, and others. The Digital Advertising Ecosystem of the company includes demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. The company operates in America, APAC, EMEA, and Rest of America, with majority revenue from America.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: